“…In the published literature, atropine has been used as a non-selective high affinity antagonist at muscarinic receptors. Pirenzepine is a relatively high affinity antagonist for Ml muscarinic receptors with intermediate affinity for M4 muscarinic receptors and lower affinity for the M2 and M3 muscarinic receptors (Lambrecht et al, 1989;Caulfield & Brown, 1991;Dorje et al, 1991;Grimm et al, 1994). (11-[[[2 -(diethylamino)methyl] -l-piperidinyl]acetyl] -5,1 1-dihydro-6H-pyridol [2,3,-b][1,4]benzodiazepine-6-one) has high affinity for the M2 muscarinic receptor, but also has affinity for the Ml muscarinic receptor with lower affinity for the M3 and M4 muscarinic receptors (Birdsall & Hulme, 1983;Giachetti et al, 1986;Hammer et al, 1986).…”